Mycoplasma pneumoniae Pneumonia

Mansel, J. Keith; Rosenow, Edward C.; Smith, Thomas F.; Martin, James W.

doi:10.1378/chest.95.3.639

Cited by 143 publications

(82 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Seasonal peaks have been reported in only some of these studies. These peaks have been reported in varying periods ranging from the end of summer to winter [14,[16][17][18][19][20]. In the present study, we observed a seasonal peak (with borderline statistical significance) in the spring, with a gradually decreasing incidence as winter approached.…”

Section: Discussionsupporting

confidence: 57%

See 1 more Smart Citation

Seasonal variation in community-acquired pneumonia

Lieberman

Porath²

1996

Eur Respir J

View full text Add to dashboard Cite

S Se ea as so on na al l v va ar ri ia at ti io on n i in n c co om mm mu un ni it ty y--a ac cq qu ui ir re ed d p pn ne eu um mo on ni ia a ABSTRACT: Seasonal variation in the incidence of disease in general, and of infectious diseases in particular, is vitally important information for epidemiologists and for clinicians who deal with these diseases. In relation to communityacquired pneumonia (CAP), the seasonal distribution of the disease and, in particular, of each of the specific aetiological agents is important. All 346 adult patients who were admitted to a regional hospital in southern Israel for CAP over a period of 1 year were included in a prospective study. As part of the study, a comprehensive diagnostic work-up was performed to identify the specific causative agents for CAP. The study findings were analysed and are presented in terms of the seasonal distribution of the disease.Thirty four percent of CAP cases occurred in the spring and only 18% in the autumn (p=0.036). Respiratory viruses CAP were predominant in the winter and spring (p=0.009), whilst Mycoplasma pneumoniae CAP reached its peak incidence of 41% in the spring compared with 15% during the winter months (p=0.054). No significant seasonal predominance was observed for the other specific aetiological agents of CAP. In 58% of the CAP patients who were hospitalized in the autumn we identified a pneumococcal aetiology, whilst this agent was found in only 32% of the cases in the winter.In contrast with popular public opinion, winter with its low temperatures is not the main reason for the development of community-acquired pneumonia. Most of the specific aetiologies for community-acquired pneumonia, with the exception of respiratory viruses and Mycoplasma pneumoniae, have no seasonal predilection.

show abstract

Section: Discussionsupporting

confidence: 57%

“…The occurrence of M. pneumoniae CAP throughout the year is a well-documented finding in the literature [1,[14][15][16][17][18][19][20]. Seasonal peaks have been reported in only some of these studies.…”

Section: Discussionmentioning

confidence: 99%

Seasonal variation in community-acquired pneumonia

Lieberman

Porath²

1996

Eur Respir J

View full text Add to dashboard Cite

show abstract

“…Most patients infected with M. pneumoniae do not develop severe pneumonia. In fact, only 3 to 10% of the infected patients actually develop pneumonia (2).…”

Section: Discussionmentioning

confidence: 99%

Successful Additional Corticosteroid Treatment in a Patient with <i>Mycoplasm</i>a <i>pneumoniae</i> Pneumonia in whom a Monobacterial Infection was Confirmed by a Molecular Method Using Bronchoalveolar Lavage Fluid

et al. 2016

View full text Add to dashboard Cite

A 23-year-old Japanese woman was admitted to A hospital due to pneumonia. IgM for Mycoplasma pneumoniae was positive, and the patient was treated with imipenem/cilastatin, clindamycin, pazufloxacin and minocycline. However, both the chest radiological findings and the symptoms became exacerbated, and she was therefore transferred to our hospital. The bronchoalveolar lavage fluid was obtained, and a 16S rRNA gene sequencing analysis revealed a monobacterial infection of Mycoplasma pneumoniae. Therefore, corticosteroid treatment in addition to minocycline was administered, and the patients symptoms, laboratory data and chest radiographs improved. Corticosteroid therapy may therefore be considered for patients with refractory M. pneumoniae pneumonia.

show abstract

“…Dado que más de la mitad de los pacientes con infección por Mycoplasma presentan crioaglutininas, la presencia de títulos > 1:32 es altamente sugerente de infección. Éstas son autoanticuerpos de tipo IgM que aglutinan eritrocitos en un rango entre los 4º y 37º 2,3 . La mayoría de las veces esta hemólisis no se traduce en manifestaciones clínicas importantes 2 , sin embargo, en casos con títulos altos la hemólisis puede ser severa 18 .…”

Section: Discussionunclassified

Hemólisis, exantema, serositis. Manifestaciones extrapulmonares del Mycoplasma pneumoniae: Reporte de un caso

Cares

et al. 2014

Rev. méd. Chile

View full text Add to dashboard Cite

show abstract

Mycoplasma pneumoniae Pneumonia

Cited by 143 publications

References 42 publications

Seasonal variation in community-acquired pneumonia

Seasonal variation in community-acquired pneumonia

Successful Additional Corticosteroid Treatment in a Patient with <i>Mycoplasm</i>a <i>pneumoniae</i> Pneumonia in whom a Monobacterial Infection was Confirmed by a Molecular Method Using Bronchoalveolar Lavage Fluid

Hemólisis, exantema, serositis. Manifestaciones extrapulmonares del Mycoplasma pneumoniae: Reporte de un caso

Contact Info

Product

Resources

About